Skip to search formSkip to main contentSkip to account menu

WT1 peptide vaccine

Known as: WT-1 vax, WT1 Analog Peptide Vaccine 
A peptide vaccine comprised of an epitope of human Wilms tumor 1 (WT-1) with potential antineoplastic activity. WT-1, a transcription factor, is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundThe optimal strategy for vaccination to induce CD8+ T cell responses against WT1 is not known.MethodsA pilot randomized… 
Review
2017
Review
2017
The identification of human Wilms' tumor gene 1 (WT1) protein-derived cytotoxic T lymphocyte (CTL) epitopes and the in vivo… 
2017
2017
In this issue of Blood, Tawara et al report the first results of a novel treatment approach with T-cell receptor transduced… 
2016
2016
Background: Wilms9 tumor gene 1 (WT1), broadly expressed in hematological malignancies and solid tumors, is a promising candidate… 
2013
2013
ObjectiveThe aim of the present study was to analyze the long-term survival effects of WT1 peptide vaccine, in addition to its… 
2006
2006
2511 Background: The transcription factor Wilms tumor protein (WT) 1 belongs to a new generation of tumor antigens, as it is…